Partnering opportunities

Antibody companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop antibody technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

13 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ | number }]} opportunities

13 opportunities

Get updates to this list Embed these results

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ }]}

UK-based SME offers access to novel bispecific antibody drug conjugate technology to companies and research institutions

There have been many innovations in the treatment of cancer one of which has been the use of antibody-drug conjugates (ADCs) where antibodies that target markers on cancer cells are linked to chemotherapy drugs.... more

United Kingdom

A Dutch multinational pharmaceutical company is looking for licensing partners of its human monoclonal antibody production platforms in the field of immuno-oncology or immunologic diseases.

generation biologics based on its two patented transgenic mouse platforms for producing fully human antibodies. Therapeutic monoclonal antibody (mAb) is one of the fastest growing segments of the global pharmaceutical... more


UK-based SME requests technical expertise to explore the synergy found in its antibody drug conjugate technology under research cooperation or technical cooperation agreements

Antibody-drug conjugates (ADCs) are a promising method of treating cancer where antibodies that target markers on cancer cells are linked to chemotherapy drugs. This enables the drug to be delivered to the cancer... more

United Kingdom

Novel combined epigenic and immunological strategy for improved cancer therapy

administration of a GD2-specific CAR-T cell or CAR-NK cell or a GD2 specific antibody to the subject. Further, the present invention relates to a GD2-specific CAR-T cell or CAR-NK cell or a GD2-specific more


Croatian academic research group offers its database of antibodies

), human cytomegalovirus (HCMV) and human (mostly) and mouse lymphocytes receptors and their ligands. The database is a collection of monoclonal antibodies (mAbs). For most of the targeted proteins, there is no other antibody... more


New combination of therapeutic agents for the treatment of lymphoid neoplasias

effect with an anti—CD20 antibody. In addition, the combination of miRNA with low doses of CHOP is therapeutically efficient and allows decreasing CHOP therapeutic concentration and its toxicity, thus reducing... more



this technology is in terms of the cost compared to the high-cost norovirus concentration method which uses an expensive antibody. Therefore, under commercial agreement with technical assistance and license... more

South Korea

An established Slovak research institute has developed a unique system for in vivo isolation of circulating tumour cells from peripheral blood and is looking for licensees or investors

innovative technology takes advantage of magnetic nanoparticles coated with a monoclonal antibody that are injected into the bloodstream via an intravenous cannula, as well as of a special wire containing a magnetic... more


Aptamer targeting hormone refractory prostate cancer

therapeutic purposes. In particular when coupled to a drug, the aptamer may be used in analogy to an antibody-drug-conjugate. The offer addresses companies from the pharmaceutical or biotechnology sector that... more


Single cell analysis systems for biotherapeutic and medical diagnostic discovery and development

could be an industry blockbuster. The platform enables the discovery and development of new biopharmaceuticals, enzymes and high production cell lines. The system will be fully-automated and can be integrated into various antibody... more

United Kingdom

Patented cell-free technology for production of active membrane proteins

partner will develop together a proof of concept. There are many applications such as vaccine development, antibody development, screening&diplay, in vitro diagnotics, structural biology and protein vectorization. The... more


Chip-integrated optical sensor

protein, antibody, or amino acid.) The developed sensor provides very specific properties due to its special geometry, which allows the transformation of the whole or of only a part of a normal or of an oblique... more


Layer-by-Layer nanoscale coatings, surface modification, micro encapsulation and bead based microsensors (pH, temperature, oxygen, chloride, bioanalysis) for co-development of innovative applications

materials throughout years of research and offers their expertise to potential partners for tailored applications. (3) Bioanalysis (antibody-antigen interactions, etc.) and determination of pH, temperature, oxygen,... more


The right partner not here?

Get in touch and we'll help you post a partnering opportunity